241 related articles for article (PubMed ID: 22402438)
1. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Nguyen T; Kuo C; Nicholl MB; Sim MS; Turner RR; Morton DL; Hoon DS
Epigenetics; 2011 Mar; 6(3):388-94. PubMed ID: 21081840
[TBL] [Abstract][Full Text] [Related]
3. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
[TBL] [Abstract][Full Text] [Related]
4. Transposable hypomethylation is associated with metastatic capacity of primary melanomas.
Ecsedi SI; Hernandez-Vargas H; Lima SC; Herceg Z; Adany R; Balazs M
Int J Clin Exp Pathol; 2013; 6(12):2943-8. PubMed ID: 24294382
[TBL] [Abstract][Full Text] [Related]
5. Long interspersed nucleotide element-1 hypomethylation in canine malignant mucosal melanoma.
Ishizaki T; Yamazaki J; Meagawa S; Yokoyama N; Aoshima K; Takiguchi M; Kimura T
Vet Comp Oncol; 2020 Dec; 18(4):854-860. PubMed ID: 32187810
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
7. Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma.
de Unamuno Bustos B; Murria Estal R; Pérez Simó G; Simarro Farinos J; Pujol Marco C; Navarro Mira M; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Br J Dermatol; 2018 Aug; 179(2):394-404. PubMed ID: 29278418
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
[TBL] [Abstract][Full Text] [Related]
9. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
10. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
[TBL] [Abstract][Full Text] [Related]
11. DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Venza M; Visalli M; Catalano T; Beninati C; Teti D; Venza I
Hum Pathol; 2017 Feb; 60():137-146. PubMed ID: 27825810
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-alpha methylation predicts melanoma progression.
Mori T; Martinez SR; O'Day SJ; Morton DL; Umetani N; Kitago M; Tanemura A; Nguyen SL; Tran AN; Wang HJ; Hoon DS
Cancer Res; 2006 Jul; 66(13):6692-8. PubMed ID: 16818643
[TBL] [Abstract][Full Text] [Related]
14. Higher methylation subtype of malignant melanoma and its correlation with thicker progression and worse prognosis.
Yamamoto Y; Matsusaka K; Fukuyo M; Rahmutulla B; Matsue H; Kaneda A
Cancer Med; 2020 Oct; 9(19):7194-7204. PubMed ID: 32406600
[TBL] [Abstract][Full Text] [Related]
15. AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.
Rosenbaum E; Begum S; Brait M; Zahurak M; Maldonado L; Mangold LA; Eisenberger MA; Epstein JI; Partin AW; Sidransky D; Hoque MO
Prostate; 2012 Jul; 72(10):1133-9. PubMed ID: 22127895
[TBL] [Abstract][Full Text] [Related]
16. Metastatic melanoma of unknown primary resembles the genotype of cutaneous melanomas.
Egberts F; Bergner I; Krüger S; Haag J; Behrens HM; Hauschild A; Röcken C
Ann Oncol; 2014 Jan; 25(1):246-50. PubMed ID: 24276025
[TBL] [Abstract][Full Text] [Related]
17. LINE-1 hypomethylation and mutational status in cutaneous melanomas.
Pramio DT; Pennacchi PC; Maria-Engler SS; Campos AH; Duprat JP; Carraro DM; Krepischi AC
J Investig Med; 2016 Apr; 64(4):899-904. PubMed ID: 26965315
[TBL] [Abstract][Full Text] [Related]
18. Association of HERV-K and LINE-1 hypomethylation with reduced disease-free survival in melanoma patients.
Cardelli M; Doorn RV; Larcher L; Donato MD; Piacenza F; Pierpaoli E; Giacconi R; Malavolta M; Rachakonda S; Gruis NA; Molven A; Andresen PA; Pjanova D; van den Oord JJ; Provinciali M; Nagore E; Kumar R
Epigenomics; 2020 Oct; 12(19):1689-1706. PubMed ID: 33125285
[No Abstract] [Full Text] [Related]
19. Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.
Rhee YY; Lee TH; Song YS; Wen X; Kim H; Jheon S; Lee CT; Kim J; Cho NY; Chung JH; Kang GH
Virchows Arch; 2015 Jun; 466(6):675-83. PubMed ID: 25772390
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
